Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |